1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
683DDA7C5B20CAC9165257E1B003A62A7
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/83DDA7C5B20CAC9165257E1B003A62A7!OpenDocument
18
19OpenDocument
2018.206.194.21
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Business Operations » Benchmarking and Quality » Medical Affairs

Document Excerpt: Medical Affairs Launch Support: Activities and Thought Leader Targeting

DB Image

ID: MD-457


Features:

10 Info Graphics

18 Data Graphics

250+ Metrics

4 Narratives


Pages/Slides: 4


Published: Pre-2018


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click "
Download Free Excerpt".


To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5354 " Medical Affairs Launch Support: Activities and Thought Leader Targeting".


Industries Profiled:
Biotech; Pharmaceutical; Health Care; Biopharmaceutical; Clinical Research; Laboratories; Consulting; Manufacturing; Consumer Products; Diagnostic; Medical Device


Companies Profiled:
Amgen; Pfizer; Onyx Pharmaceuticals; ProStrakan; Merz Pharma; Purdue Pharma; Medunik Canada; Sanofi; Janssen; UCB Pharma; Merck; Upsher-Smith; Insys Therapeutics; Xenoport; Jazz Pharmaceuticals; Astellas; Lundbeck; Insyght; Axon Pharma; Bayer; Baxter BioScience; Boehringer Ingelheim; Eisai; Incyte

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.